Objective: The PI3K/AKT pathway is a major signaling pathway frequently activated in human cancer due to PIK3CA and AKT1 gene mutations thus representing a potential therapeutic target and prognostic biomarker. In this study, we examined the mutational status of PIK3CA and AKT1 in meningiomas.